Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: When is a full staging procedure unnecessary?

International Journal of Gynecological Pathology

Volumn 27, Issue 1, 2008, Pages 10-17

  Allison, Kimberly H ^a   Swisher, Elizabeth M ^a   Kerkering, Katrina M ^b   Garcia, Rochelle L ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Borderline; Borderline change; Low malignant potential; Ovary; Staging

Indexed keywords

NICKEL;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CYSTADENOMA; FEMALE; FEMALE FERTILITY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; TUMOR DIAGNOSIS; TUMOR GROWTH; METHODOLOGY; OVARY TUMOR;

CYSTADENOMA, SEROUS; FEMALE; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 39349094701     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/pgp.0b013e318133a9b7     Document Type: Article

References (20)

1. Sherman ME, Berman J, Birrer MJ, et al. Current challenges and opportunities for research on borderline ovarian tumors. Hum Pathol 2004;35:961-70.
2. Silverberg SG, Bell DA, Kurman RJ, et al. Borderline ovarian tumors: key points and workshop summary. Hum Pathol 2004;35:910-7.
3. Bell DA, Longacre TA, Prat J, et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol 2004;35:934-48.
4. Longacre TA, McKenney JK, Tazelaar HD, et al. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol 2005;29:707-23.
5. Cheng EJ, Kurman RJ, Wang M, et al. Molecular genetic analysis of ovarian serous cystadenomas. Lab Invest 2004;84:778-84.
6. Ho CL, Kurman RJ, Dehari R, et al. Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors. Cancer Res 2004;64:6915-8.
7. Lee KR, Tavassoli FA, Prat J, et al. Tumors of the ovary and peritoneum: surface epithelial-stromal tumours. In: Tavassoli FA, Devilee P, eds. WHO Classification: Tumors of the Breast and Female Genital Organs. Lyon, France: IAPRC Press, 2003:119-24.
8. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996;20:1319-30.
9. Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999;23:397-409.
10. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990;21:397-403.
11. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer 1988;62:2212-22.
12. Obstetrics IFoGa. Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 1989;28:189-90.
13. Rao GG, Skinner E, Gehrig PA, et al. Surgical staging of ovarian low malignant potential tumors. Obstet Gynecol 2004;104:261-6.
14. Humphrey PA, Vollmer RT. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol 1997;10:326-33.
15. Houck K, Nikrui N, Duska L, et al. Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol 2000;95:839-43.
16. Pinto PB, Andrade LA, Derchain SF. Accuracy of intraoperative frozen section diagnosis of ovarian tumors. Gynecol Oncol 2001;81:230-2.
17. Rose PG, Rubin RB, Nelson BE, et al. Accuracy of frozen-section (intraoperative consultation) diagnosis of ovarian tumors. Am J Obstet Gynecol 1994;171:823-6.
18. Yeo EL, Yu KM, Poddar NC, et al. The accuracy of intraoperative frozen section in the diagnosis of ovarian tumors. J Obstet Gynaecol Res 1998;24:189-95.
19. Barnhill DR, Kurman RJ, Brady MF, et al. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol 1995;13:2752-6.
20. Silva EG, Gershenson DM, Malpica A, et al. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol 2006;30:1367-71.